Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis.

Mishra R, Kohli S, Malhotra N, Bandyopadhyay P, Mehta M, Munshi M, Adiga V, Ahuja VK, Shandil RK, Rajmani RS, Seshasayee ASN, Singh A.

Sci Transl Med. 2019 Nov 13;11(518). pii: eaaw6635. doi: 10.1126/scitranslmed.aaw6635.

PMID:
31723039
2.

Genotypic background of the recipient plant is crucial for conferring RB gene mediated late blight resistance in potato.

Shandil RK, Chakrabarti SK, Singh BP, Sharma S, Sundaresha S, Kaushik SK, Bhatt AK, Sharma NN.

BMC Genet. 2017 Mar 9;18(1):22. doi: 10.1186/s12863-017-0490-x.

3.

Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense.

Kaur P, Datta S, Shandil RK, Kumar N, Robert N, Sokhi UK, Guptha S, Narayanan S, Anbarasu A, Ramaiah S.

PLoS One. 2016 May 4;11(5):e0154513. doi: 10.1371/journal.pone.0154513. eCollection 2016.

4.

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Shirude PS, Shandil RK, Manjunatha MR, Sadler C, Panda M, Panduga V, Reddy J, Saralaya R, Nanduri R, Ambady A, Ravishankar S, Sambandamurthy VK, Humnabadkar V, Jena LK, Suresh RS, Srivastava A, Prabhakar KR, Whiteaker J, McLaughlin RE, Sharma S, Cooper CB, Mdluli K, Butler S, Iyer PS, Narayanan S, Chatterji M.

J Med Chem. 2014 Jul 10;57(13):5728-37. doi: 10.1021/jm500571f. Epub 2014 Jun 20.

PMID:
24874895
5.

Pharmacokinetics and dose response of anti-TB drugs in rat infection model of tuberculosis.

Kumar N, Vishwas KG, Kumar M, Reddy J, Parab M, Manikanth CL, Pavithra BS, Shandil RK.

Tuberculosis (Edinb). 2014 May;94(3):282-6. doi: 10.1016/j.tube.2014.02.004. Epub 2014 Feb 21.

6.

Complete Genome Sequence of Potato leafroll virus Isolates Infecting Potato in the Different Geographical Areas of India Shows Low Level Genetic Diversity.

Jeevalatha A, Kaundal P, Shandil RK, Sharma NN, Chakrabarti SK, Singh BP.

Indian J Virol. 2013 Sep;24(2):199-204. doi: 10.1007/s13337-013-0138-z. Epub 2013 May 18.

7.

Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.

Balasubramanian V, Solapure S, Gaonkar S, Mahesh Kumar KN, Shandil RK, Deshpande A, Kumar N, Vishwas KG, Panduga V, Reddy J, Ganguly S, Louie A, Drusano GL.

Antimicrob Agents Chemother. 2012 Jun;56(6):3054-7. doi: 10.1128/AAC.06383-11. Epub 2012 Apr 2.

8.

Aerosol infection model of tuberculosis in wistar rats.

Gaonkar S, Bharath S, Kumar N, Balasubramanian V, Shandil RK.

Int J Microbiol. 2010;2010:426035. doi: 10.1155/2010/426035. Epub 2010 Mar 18.

9.

Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice.

Awasthy D, Gaonkar S, Shandil RK, Yadav R, Bharath S, Marcel N, Subbulakshmi V, Sharma U.

Microbiology. 2009 Sep;155(Pt 9):2978-87. doi: 10.1099/mic.0.029884-0. Epub 2009 Jun 18.

PMID:
19542000
10.

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Makarov V, Manina G, Mikusova K, Möllmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP, Milano A, De Rossi E, Belanova M, Bobovska A, Dianiskova P, Kordulakova J, Sala C, Fullam E, Schneider P, McKinney JD, Brodin P, Christophe T, Waddell S, Butcher P, Albrethsen J, Rosenkrands I, Brosch R, Nandi V, Bharath S, Gaonkar S, Shandil RK, Balasubramanian V, Balganesh T, Tyagi S, Grosset J, Riccardi G, Cole ST.

Science. 2009 May 8;324(5928):801-4. doi: 10.1126/science.1171583. Epub 2009 Mar 19.

11.

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.

Shandil RK, Jayaram R, Kaur P, Gaonkar S, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Balasubramanian V.

Antimicrob Agents Chemother. 2007 Feb;51(2):576-82. Epub 2006 Dec 4.

12.

Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.

Jayaram R, Shandil RK, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Kantharaj E, Balasubramanian V.

Antimicrob Agents Chemother. 2004 Aug;48(8):2951-7.

13.

High-throughput screen for inhibitors of transglycosylase and/or transpeptidase activities of Escherichia coli penicillin binding protein 1b.

Chandrakala B, Shandil RK, Mehra U, Ravishankar S, Kaur P, Usha V, Joe B, deSousa SM.

Antimicrob Agents Chemother. 2004 Jan;48(1):30-40.

14.

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.

Jayaram R, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharat S, Shandil RK, Kantharaj E, Balasubramanian V.

Antimicrob Agents Chemother. 2003 Jul;47(7):2118-24.

17.

Immunological approaches in the diagnosis of amoebiasis.

Vinayak VK, Shandil RK.

Trop Gastroenterol. 1991 Oct-Dec;12(4):165-75. Review. No abstract available.

PMID:
1814027
18.

Monoclonal antibodies which inhibit in vitro cytotoxicity of axenic Entamoeba histolytica.

Shandil RK, Kaur U, Vinayak VK.

Indian J Med Res. 1991 Sep;93:311-7.

PMID:
1778619
20.
21.

Uses and limitations in the demonstration of specific circulating immune complexes in patients with amoebiasis.

Vinayak VK, Shandil RK, Bansal V, Singh K, Bhasin DK, Kaur U.

J Med Microbiol. 1990 Jun;32(2):87-91.

PMID:
2355392
22.

Immunoreactivity of Entamoeba histolytica antigens with sera from amoebic patients.

Shandil RK, Vinayak VK.

Med Microbiol Immunol. 1990;179(5):263-9.

PMID:
2082159
23.

Characteristics of Escherichia coli isolates from infantile and childhood diarrhea.

Jayasheela M, Kumari N, Shandil RK, Saxena SN.

Indian J Pediatr. 1989 Jan-Feb;56(1):87-92.

PMID:
2684854

Supplemental Content

Loading ...
Support Center